300254 仟源医药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)7.0088.9474.288-20.358-14.326
总资产报酬率 ROA (%)1.4422.8311.670-7.619-5.496
投入资产回报率 ROIC (%)2.1814.0202.145-9.679-7.129

边际利润分析
销售毛利率 (%)67.72366.90867.78869.73569.668
营业利润率 (%)11.5877.6775.024-13.883-8.553
息税前利润/营业总收入 (%)15.51911.39110.612-5.669-1.958
净利润/营业总收入 (%)7.9278.8306.096-11.812-8.012

收益指标分析
经营活动净收益/利润总额(%)76.65367.396-7.07073.038111.511
价值变动净收益/利润总额(%)1.8995.63537.7763.811-20.829
营业外收支净额/利润总额(%)8.42119.40527.361-27.853-21.525

偿债能力分析
流动比率 (X)0.9160.8770.9630.8470.940
速动比率 (X)0.6760.6450.6760.6750.669
资产负债率 (%)62.76361.35145.68153.94551.233
带息债务/全部投入资本 (%)50.79344.10835.98448.27920.571
股东权益/带息债务 (%)56.22676.461154.16893.972242.480
股东权益/负债合计 (%)30.24736.12291.67367.26875.349
利息保障倍数 (X)5.4156.1062.871-1.093-0.385

营运能力分析
应收账款周转天数 (天)70.82154.49047.10649.50762.705
存货周转天数 (天)183.777162.948156.661151.840147.229